论文信息 - Placebocontrolled Phase 3 Trial of a Recombinant Glycoprotein 120 Vaccine to Prevent HIV-1 InfectionGurwith M, for the rgp 120 HIV Vaccine Study Group (VaxGen, Brisbane, Calif; et al) J Infect Dis 191:654–665, 2005§ - 字舞流文

Placebocontrolled Phase 3 Trial of a Recombinant Glycoprotein 120 Vaccine to Prevent HIV-1 InfectionGurwith M, for the rgp 120 HIV Vaccine Study Group (VaxGen, Brisbane, Calif; et al) J Infect Dis 191:654–665, 2005§

D Sydman | D. Sydman

[1] Kenneth H Mayer,et al. Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection. , 2005, The Journal of infectious diseases.